Suppr超能文献

米兰系统在下颌下腺细针穿刺抽吸细胞学风险分层中的应用

Usage of Milan System in Risk Stratification of Submandibular Gland Fine Needle Aspiration Cytology.

作者信息

Yew Wan Xin, Choy Kevin C C, Bundele Manish M, Fu Ernest W, Li Hao, Lim Ming Yann, Gan Yijin Jereme

机构信息

Department of Otorhinolaryngology, Woodlands Health Campus, Singapore, Singapore.

Department of Otorhinolaryngology, Tan Tock Seng Hospital, Singapore, Singapore.

出版信息

Laryngoscope. 2025 Jul;135(7):2392-2398. doi: 10.1002/lary.32019. Epub 2025 Jan 24.

Abstract

OBJECTIVES

The Milan System for Reporting Salivary Gland Cytopathology (MSRSGC) categorizes fine needle aspiration and cytology (FNAC) results into 6 tiers and assigns a risk of malignancy (ROM) to each category. Its utility in submandibular gland lesions remains unclear. Our article aims to study (1) the utility of the MSRSGC in classifying FNAC of submandibular gland masses, (2) describe the demographics and incidence of submandibular gland malignancy in our population, and (3) analyze the accuracy of FNAC in diagnosis of benign and malignant submandibular gland tumors.

METHODS

In this retrospective case series, the FNAC results of 92 patients who underwent pre-operative FNAC and excision of submandibular gland between May 2008 and December 2023 were reviewed and assigned to a MSRSGC category, and ROM was calculated based on histological diagnosis.

RESULTS

20/92 (21.7%) submandibular gland excisions with pre-operative FNAC were malignant. ROM is as follows: non-diagnostic 7.1%, non-neoplastic 12.5%, atypia of undetermined significance 35.3%, benign neoplasm 3.3%, salivary gland neoplasm of uncertain malignant potential 35%, suspicious for malignancy 100%, and malignant 100%.

CONCLUSION

Our study validates the usage of the MSRSGC in the work up of submandibular gland tumors.

LEVEL OF EVIDENCE

4 Laryngoscope, 135:2392-2398, 2025.

摘要

目的

米兰唾液腺细胞病理学报告系统(MSRSGC)将细针穿刺抽吸及细胞学检查(FNAC)结果分为6个等级,并为每个等级赋予恶性风险(ROM)。其在下颌下腺病变中的效用尚不清楚。我们的文章旨在研究(1)MSRSGC在分类下颌下腺肿块FNAC中的效用,(2)描述我们人群中下颌下腺恶性肿瘤的人口统计学特征和发病率,以及(3)分析FNAC在诊断下颌下腺良恶性肿瘤中的准确性。

方法

在这个回顾性病例系列中,回顾了2008年5月至2023年12月期间92例行术前FNAC及下颌下腺切除术患者的FNAC结果,并将其归入MSRSGC类别,根据组织学诊断计算ROM。

结果

92例术前FNAC的下颌下腺切除术中,20例(21.7%)为恶性。ROM如下:无法诊断7.1%,非肿瘤性12.5%,意义不明确的异型性35.3%,良性肿瘤3.3%,恶性潜能不确定的唾液腺肿瘤35%,可疑恶性100%,恶性100%。

结论

我们的研究验证了MSRSGC在下颌下腺肿瘤检查中的应用。

证据水平

4 《喉镜》,135:2392 - 2398,2025年。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验